Genex Pharmaceutical Stock Performance
| GENX Stock | USD 0.0001 0.00 0.00% |
The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Genex Pharmaceutical are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Genex Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Genex Pharmaceutical is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors. ...more
Genex |
Genex Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 0.01 in Genex Pharmaceutical on September 30, 2025 and sell it today you would earn a total of 0.00 from holding Genex Pharmaceutical or generate 0.0% return on investment over 90 days. Genex Pharmaceutical is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Genex, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Genex Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Genex Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Genex Pharmaceutical, and traders can use it to determine the average amount a Genex Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| GENX |
Based on monthly moving average Genex Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genex Pharmaceutical by adding Genex Pharmaceutical to a well-diversified portfolio.
Genex Pharmaceutical Fundamentals Growth
Genex Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Genex Pharmaceutical, and Genex Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Genex Pink Sheet performance.
| Return On Equity | 0.0778 | |||
| Return On Asset | 0.0405 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.14 % | |||
| Current Valuation | 110.64 K | |||
| Price To Earning | 0.01 X | |||
| Price To Book | 0.08 X | |||
| Price To Sales | 0.03 X | |||
| Revenue | 3.24 M | |||
| EBITDA | 522.28 K | |||
| Cash And Equivalents | 430.12 K | |||
| Cash Per Share | 0.02 X | |||
| Debt To Equity | 0.12 % | |||
| Book Value Per Share | 0.27 X | |||
| Cash Flow From Operations | 529.66 K | |||
| Total Asset | 8.65 M | |||
| Retained Earnings | 2.53 M | |||
| Current Asset | 2.14 M | |||
| Current Liabilities | 3.48 M | |||
About Genex Pharmaceutical Performance
Evaluating Genex Pharmaceutical's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Genex Pharmaceutical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Genex Pharmaceutical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft in the Peoples Republic of China. Genex Pharmaceutical is headquartered in Tianjin City, the Peoples Republic of China. Genex Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 86 people.Things to note about Genex Pharmaceutical performance evaluation
Checking the ongoing alerts about Genex Pharmaceutical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Genex Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Genex Pharmaceutical generated a negative expected return over the last 90 days | |
| Genex Pharmaceutical has some characteristics of a very speculative penny stock | |
| The company has a current ratio of 0.61, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Genex Pharmaceutical until it has trouble settling it off, either with new capital or with free cash flow. So, Genex Pharmaceutical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Genex Pharmaceutical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Genex to invest in growth at high rates of return. When we think about Genex Pharmaceutical's use of debt, we should always consider it together with cash and equity. | |
| Latest headline from news.google.com: Can Bal Pharma Limited Rally Enough to Break Even - Utilities Sector Analysis Free Explosive Return Secrets - Bollywood Helpline |
- Analyzing Genex Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Genex Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining Genex Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Genex Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Genex Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Genex Pharmaceutical's pink sheet. These opinions can provide insight into Genex Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Genex Pink Sheet Analysis
When running Genex Pharmaceutical's price analysis, check to measure Genex Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genex Pharmaceutical is operating at the current time. Most of Genex Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Genex Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genex Pharmaceutical's price. Additionally, you may evaluate how the addition of Genex Pharmaceutical to your portfolios can decrease your overall portfolio volatility.